| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1.1 | 0.0 |
| Gross profit | 0.5 | 0.0 |
| Net income | -0.5 | -0.6 |
| EPS (diluted, $ a share) | $-0.02 | $-0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +18296.5% |
|---|---|
| Gross margin | 45.4% |
| Operating margin | -41.3% |
10-Q filed with the SEC, OTC: PMHS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Polomar Health Services, Inc.: key numbers
- Share price
- $0.1250Close, Nov 13
- Market cap
- $3.55M
- Shares outstanding
- 28.38MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Polomar Health Services, Inc.
All →Polomar Health Services Debt Financing Update with Island 40 Group, LLC
Polomar Health Services executed a $450,000 promissory note and loan agreement with Island 40 Group, LLC to settle outstanding commissions owed for sales and distribution services. The note bears an initial 10% interest rate and is guaranteed by the company's wholly owned subsidiary, Polomar Specialty Pharmacy, LLC. The debt matures on March 31, 2027, and represents the formalization of a direct financial obligation for past services.
- Counterparty
- Island 40 Group, LLC
- Term
- through March 31, 2027
Polomar Health Services Other 8-K Filing
Polomar Health Services announced that its financial statements for the first and second quarters of 2026 can no longer be relied upon due to accounting errors. The company identified unrecorded expenses, revenue recognition issues, and the misclassification of preferred stock, which are expected to increase its aggregate net loss by approximately $421,000. Polomar intends to restate these periods and expects to report one or more material weaknesses in its internal controls.
Polomar Health Services Leadership Change
Alexandra Peterson and Gabrielle Toledano resigned from the Board of Directors of Polomar Health Services, Inc., effective October 14, 2026. Following these departures, the Board reduced its size from five to three directors. The company stated the resignations were not due to any disagreements regarding operations, policies, or practices.